Ferroptosis regulation by the NGLY1/NFE2L1 pathway

Ferroptosis is an oxidative form of non-apoptotic cell death whose transcriptional regulation is poorly understood. Cap’n’collar (CNC) transcription factors including Nuclear Factor Erythroid-2 Related Factor 1 (NFE2L1/NRF1) and NFE2L2 (NRF2) are important regulators of oxidative stress responses. Here, we report that NFE2L1 expression inhibits ferroptosis, independent of NFE2L2. NFE2L1 inhibits ferroptosis by promoting expression of the key anti-ferroptotic lipid hydroperoxidase glutathione peroxidase 4 (GPX4). NFE2L1 abundance and function are regulated post-translationally by N-glycosylation. Functional maturation of NFE2L1 requires deglycosylation by cytosolic peptide:N-glycanase 1 (NGLY1). We find that loss of NGLY1 or NFE2L1 enhances ferroptosis sensitivity. Expression of wild-type NGLY1 but not a disease-associated NGLY1 mutant inhibits ferroptosis, and this effect is dependent on the presence of NFE2L1. Enhanced ferroptosis sensitivity in NFE2L1 and NFE2L2 knockout cells can be potently reverted by expression of an NFE2L1 mutant containing eight asparagine-to-aspartate protein sequence substitutions, which mimic NGLY1-catalyzed sequence editing. Enhanced ferroptosis sensitivity in NGLY1/NFE2L1 pathway mutants could also be reversed by overexpression of NFE2L2. These results suggest that ferroptosis sensitivity is regulated by NGLY1-catalyzed NFE2L1 deglycosylation, and highlight a broad role for CNC transcription factors in ferroptosis regulation. Significance Statement Ferroptosis is an oxidative form of cell death whose biochemical regulation remains incompletely understood. NFE2L1/NRF1 is a cap’n’collar (CNC) transcription factor whose role in ferroptosis regulation is unclear. Unlike the CNC family member NFE2L2/NRF2, NFE2L1 is an N-glycoprotein whose abundance is regulated by post-translational deglycosylation catalyzed by the enzyme peptide:N-glycanase 1 (NGLY1). Our results indicate that NGLY1-mediated NFE2L1 deglycosylation, resulting in ‘editing’ of the NFE2L1 amino acid sequence, is necessary for NFE2L1 to inhibit ferroptosis. Mechanistically, NFE2L1 inhibits ferroptosis by via the anti-ferroptotic protein GPX4. This work demonstrates that CNC transcription factors beyond NFE2L2 can regulate ferroptosis. This work may suggest a role of misregulation of ferroptosis in NGLY1 deficiency, an ultrarare genetic disorder.

[1]  Keiji Tanaka,et al.  Loss of peptide:N-glycanase causes proteasome dysfunction mediated by a sugar-recognizing ubiquitin ligase , 2021, Proceedings of the National Academy of Sciences.

[2]  S. Dixon,et al.  A Compendium of Kinetic Modulatory Profiles Identifies Ferroptosis Regulators , 2021, Nature Chemical Biology.

[3]  B. Stockwell,et al.  Ferroptosis: mechanisms, biology and role in disease , 2021, Nature Reviews Molecular Cell Biology.

[4]  S. Dixon,et al.  Quantification of drug-induced fractional killing using high-throughput microscopy , 2021, STAR protocols.

[5]  D. Tang,et al.  MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells. , 2021, Cell chemical biology.

[6]  C. Lutz,et al.  A Drosophila screen identifies NKCC1 as a modifier of NGLY1 deficiency , 2020, eLife.

[7]  T. Cowan,et al.  A conserved role for AMP-activated protein kinase in NGLY1 deficiency , 2020, PLoS genetics.

[8]  S. Gygi,et al.  3D Culture Models with CRISPR Screens Reveal Hyperactive NRF2 as a Prerequisite for Spheroid Formation via Regulation of Proliferation and Ferroptosis. , 2020, Molecular cell.

[9]  M. Murphy,et al.  Functional interplay among thiol-based redox signaling, metabolism, and ferroptosis unveiled by a genetic variant of TP53 , 2020, Proceedings of the National Academy of Sciences.

[10]  M. Affolter,et al.  Regulation of BMP4/Dpp retrotranslocation and signaling by deglycosylation , 2020, eLife.

[11]  B. Blagoev,et al.  DDI2 Is a Ubiquitin-Directed Endoprotease Responsible for Cleavage of Transcription Factor NRF1 , 2020, Molecular cell.

[12]  I. Harris,et al.  Non-canonical glutamate-cysteine ligase activity protects against ferroptosis , 2020, bioRxiv.

[13]  S. Quintas,et al.  NGLY1 deficiency—A rare congenital disorder of deglycosylation , 2020, JIMD reports.

[14]  Stephen A. Sastra,et al.  Cysteine depletion induces pancreatic tumor ferroptosis in mice , 2020, Science.

[15]  H. Freeze,et al.  N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity. , 2019, Cell reports.

[16]  Xiaolin Lin,et al.  Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance , 2019, British Journal of Cancer.

[17]  E. Perlstein,et al.  Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches , 2019, Disease Models & Mechanisms.

[18]  D. Hsu,et al.  The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. , 2019, Cell reports.

[19]  B. Stockwell,et al.  Intercellular interaction dictates cancer cell ferroptosis via Merlin-YAP signalling , 2019, Nature.

[20]  Emanuel J. V. Gonçalves,et al.  Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens , 2019, Nature.

[21]  M. Murphy,et al.  Mechanistic basis for impaired ferroptosis in cells expressing the African-centric S47 variant of p53 , 2019, Proceedings of the National Academy of Sciences.

[22]  Gary Ruvkun,et al.  Protein Sequence Editing of SKN-1A/Nrf1 by Peptide:N-Glycanase Controls Proteasome Gene Expression , 2019, Cell.

[23]  J. Olzmann,et al.  Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State. , 2019, Cell chemical biology.

[24]  E. Perlstein,et al.  Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches , 2019, Disease Models & Mechanisms.

[25]  S. Dixon,et al.  A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity , 2019, Cell reports.

[26]  Donna D. Zhang,et al.  NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis , 2019, Redox biology.

[27]  Nan Yan,et al.  N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1 , 2018, The Journal of experimental medicine.

[28]  G. Sethi,et al.  Antioxidant response elements: Discovery, classes, regulation and potential applications , 2018, Redox biology.

[29]  Matthew Might,et al.  Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches , 2018, Human molecular genetics.

[30]  S. Dixon,et al.  p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells. , 2018, Cell reports.

[31]  M. Falk,et al.  Mitochondrial function requires NGLY1. , 2018, Mitochondrion.

[32]  B. Brüne,et al.  Nrf2, the Master Regulator of Anti-Oxidative Responses , 2017, International journal of molecular sciences.

[33]  Carolyn R. Bertozzi,et al.  Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity , 2017, ACS central science.

[34]  M. Rauh,et al.  Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis , 2017, Oncogenesis.

[35]  Phillip G. Montgomery,et al.  Defining a Cancer Dependency Map , 2017, Cell.

[36]  S. Dixon,et al.  Systematic Quantification of Population Cell Death Kinetics in Mammalian Cells. , 2017, Cell systems.

[37]  Masayuki Yamamoto,et al.  Small Maf proteins (MafF, MafG, MafK): History, structure and function. , 2016, Gene.

[38]  D. Tang,et al.  Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells , 2016, Hepatology.

[39]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[40]  Matthew E. Welsch,et al.  Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.

[41]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[42]  Shelly C. Lu.  Glutathione synthesis. , 2013, Biochimica et biophysica acta.

[43]  Yuichiro J Suzuki,et al.  Faculty Opinions recommendation of Ferroptosis: an iron-dependent form of nonapoptotic cell death. , 2012 .

[44]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[45]  E. Krüger,et al.  Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. , 2010, Molecular cell.

[46]  R. Deshaies,et al.  Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. , 2010, Molecular cell.

[47]  G. Sykiotis,et al.  Stress-Activated Cap'n'collar Transcription Factors in Aging and Human Disease , 2010, Science Signaling.

[48]  A. Mesecar,et al.  Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. , 2009, The Biochemical journal.

[49]  G. Baumann,et al.  Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. , 2009, Cardiovascular research.

[50]  J. Harper,et al.  The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase , 2004, Molecular and Cellular Biology.

[51]  Laura Leung,et al.  Deficiency of the Nrf1 and Nrf2 Transcription Factors Results in Early Embryonic Lethality and Severe Oxidative Stress* , 2003, Journal of Biological Chemistry.

[52]  D. Ginzinger,et al.  Nrf1 Is Critical for Redox Balance and Survival of Liver Cells during Development , 2003, Molecular and Cellular Biology.

[53]  Y. Kan,et al.  The CNC Basic Leucine Zipper Factor, Nrf1, Is Essential for Cell Survival in Response to Oxidative Stress-inducing Agents , 1999, The Journal of Biological Chemistry.

[54]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[55]  Y. Kan,et al.  Targeted disruption of the ubiquitous CNC‐bZIP transcription factor, Nrf‐1, results in anemia and embryonic lethality in mice , 1998, The EMBO journal.

[56]  Y. Kan,et al.  NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.